BOUCHERVILLE, Québec, April 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the ...
BOUCHERVILLE, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the launch ...
LSL Pharma Group Inc ( (TSE:LSL)) has provided an update. LSL Pharma Group has closed a $10 million initial tranche of an upsized $12 million private placement of unsecured convertible debentures, ...
Transaction expected to add $8-10 million of revenues, expand capacity and service offering Transaction is highly complementary and will enable significant synergies Closing expected to take place in ...
BOUCHERVILLE, QC, Dec. 17, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (The "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has entered ...
BOUCHERVILLE, QC, Jan. 28, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (The "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has secured ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The transaction represents 5th Century Partners' sixth investment from Fund I and further expands the firm's role in healthcare CHICAGO, Dec. 15, 2022 /PRNewswire/ -- 5th Century Partners, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results